IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $341,000 | -5.5% | 55,835 | -1.2% | 0.00% | – |
| Q4 2022 | $361,000 | -43.1% | 56,509 | -11.5% | 0.00% | -100.0% |
| Q3 2022 | $634,000 | -13.5% | 63,856 | -3.8% | 0.00% | 0.0% |
| Q2 2022 | $733,000 | -31.9% | 66,393 | +2.7% | 0.00% | 0.0% |
| Q1 2022 | $1,077,000 | -2.2% | 64,672 | +12.2% | 0.00% | 0.0% |
| Q4 2021 | $1,101,000 | -7.3% | 57,653 | +19.7% | 0.00% | 0.0% |
| Q3 2021 | $1,188,000 | -8.5% | 48,181 | -3.4% | 0.00% | 0.0% |
| Q2 2021 | $1,298,000 | -5.9% | 49,881 | +14.6% | 0.00% | -50.0% |
| Q1 2021 | $1,379,000 | -23.6% | 43,538 | +11.8% | 0.00% | -33.3% |
| Q4 2020 | $1,806,000 | +7.6% | 38,929 | -23.6% | 0.00% | 0.0% |
| Q3 2020 | $1,679,000 | +17.2% | 50,975 | -2.3% | 0.00% | +50.0% |
| Q2 2020 | $1,432,000 | +5.4% | 52,164 | +15.0% | 0.00% | -33.3% |
| Q1 2020 | $1,358,000 | -20.2% | 45,355 | -26.2% | 0.00% | +50.0% |
| Q4 2019 | $1,702,000 | +47.0% | 61,492 | -3.4% | 0.00% | 0.0% |
| Q3 2019 | $1,158,000 | -75.2% | 63,624 | -66.6% | 0.00% | -33.3% |
| Q2 2019 | $4,677,000 | +537.2% | 190,770 | +147.1% | 0.00% | +200.0% |
| Q1 2019 | $734,000 | – | 77,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |